Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots

ACS Nano

Volumn 4, Issue 5, 2010, Pages 2755-2765

  Liu, Jian ^a   Lau, Stephen K ^b   Varma, Vijay A ^b   Moffitt, Richard A ^c   Caldwell, Matthew ^c   Liu, Tao ^a   Young, Andrew N ^d   Petros, John A ^b,e,f   Osunkoya, Adeboye O ^b,d,e,f   Krogstad, Tracey ^d   Leyland Jones, Brian ^f   Wang, May D ^c   Nie, Shuming ^a  

^a EMORY UNIVERSITY   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d Laboratory Medicine   (United States)

^e School of Medicine ^*  (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Immunohistochemistry; Multiplexing; Prostate cancer; Quantum dot; Spectral imaging; Tumor heterogeneity

Indexed keywords

IMMUNOHISTOCHEMISTRY; PROSTATE CANCERS; QUANTUM DOT; SPECTRAL IMAGING; TUMOR HETEROGENEITY;

BIOMARKERS; BIOPSY; CELLS; MULTIPLEXING; OPTICAL WAVEGUIDES; SEMICONDUCTOR QUANTUM DOTS; TUMORS; UROLOGY; VISUALIZATION;

PHOTOMAPPING;

ANTIBODY CONJUGATE; QUANTUM DOT; TUMOR MARKER;

ANIMAL; ARTICLE; CHEMISTRY; HUMAN; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; MOUSE; NANOTECHNOLOGY; PATHOLOGY; PROSTATE TUMOR; RABBIT; REPRODUCIBILITY; SPECTROFLUOROMETRY; STAINING;

ANIMALS; HUMANS; IMMUNOCONJUGATES; MALE; MICE; MOLECULAR IMAGING; NANOTECHNOLOGY; PROSTATIC NEOPLASMS; QUANTUM DOTS; RABBITS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 77952944101     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn100213v     Document Type: Article

References (45)

1. Alivisatos, A. P. The Use of Nanocrystals in Biological Detection Nat. Biotechnol. 2004, 22, 47-52
2. Michalet, X.; Pinaud, F. F.; Bentolila, L. A.; Tsay, J. M.; Doose, S.; Li, J. J.; Sundaresan, G.; Wu, A. M.; Gambhir, S. S.; Weiss, S. Quantum Dots for Live Cells, In Vivo Imaging, and Diagnostics Science 2005, 307, 538-544
3. Gao, X. H.; Yang, L.; Petros, J. A.; Marshall, F. F.; Simons, J. W.; Nie, S. M. In Vivo Molecular and Cellular Imaging with Quantum Dots Curr. Opin. Biotechnol. 2005, 16, 63-72
4. Smith, A. M.; Duan, H.; Mohs, A. M.; Nie, S. M. Bioconjugated Quantum Dots for In Vivo Molecular and Cellular Imaging Adv. Drug Delivery Rev. 2008, 60, 1226-1240
5. Xing, Y.; Chaudry, Q.; Shen, C.; Kong, K. Y.; Zhau, H. E.; Chung, L. W.; Petros, J. A.; O'Regan, R. M.; Yezhelyev, M. V.; Simons, J. W. et al. Bioconjugated Quantum Dots for Multiplexed and Quantitative Immunohistochemistry Nat. Protoc. 2007, 2, 1152-1165
6. Yezhelyev, M. V.; Al-Hajj, A.; Morris, C.; Marcus, A. I.; Liu, T.; Lewis, M.; Cohen, C.; Zrazhevskiy, P.; Simons, J. W.; Rogatko, A. et al. In Situ Molecular Profiling of Breast Cancer Biomarkers With Multicolor Quantum Dots Adv. Mater. 2007, 19, 3146-3151
7. Smith, A. M.; Dave, S.; Nie, S. M.; True, L.; Gao, X. H. Multicolor Quantum Dots for Molecular Diagnostics of Cancer Expert Rev. Mol. Diagn. 2006, 6, 231-244
8. Ghazani, A. A.; Lee, J. A.; Klostranec, J.; Xiang, Q.; Dacosta, R. S.; Wilson, B. C.; Tsao, M. S.; Chan, W. C. W. High Throughput Quantification of Protein Expression of Cancer Antigens in Tissue Microarray Using Quantum Dot Nanocrystals Nano Lett. 2006, 6, 2881-1886
9. Fountaine, T. J.; Wincovitch, S. M.; Geho, D. H.; Garfield, S. H.; Pittaluga, S. Multispectral Imaging of Clinically Relevant Cellular Targets in Tonsil and Lymphoid Tissue Using Semiconductor Quantum Dots Modern Pathol. 2006, 19, 1181-1191
10. Sweeney, E.; Ward, T. H.; Gray, N.; Womack, C.; Jayson, G.; Hughes, A.; Dive, C.; Byers, R. Quantitative Multiplexed Quantum Dot Immunohistochemistry Biochem. Biophys. Res. Commun. 2008, 374, 181-186
11. Tholouli, E.; Sweeney, E.; Barrow, E.; Clay, V.; Hoyland, J. A.; Byers, R. J. Quantum Dots Light Up Pathology J. Pathol. 2008, 216, 275-285
12. Nie, S. M.; Xing, Y.; Kim, G. J.; Simons, J. W. Nanotechnology Applications in Cancer Annu. Rev. Biomed. Eng. 2007, 9, 257-288
13. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges Nat. Rev. Cancer 2005, 5, 161-171
14. Heath, J. R.; Davis, M. E. Nanotechnology and Cancer Annu. Rev. Med. 2008, 59, 251-265
15. Chen, C.; Peng, J.; Xia, H.-S.; Yang, G.-F.; Wu, Q.-S.; Chen, L.-D.; Zeng, L.-B.; Zhang, Z.-L.; Pang, D.-W.; Li, Y. Quantum Dots-Based Immunofluorescence Technology for the Quantitative Determination of HER2 Expression in Breast Cancer Biomaterials 2009, 30, 2912-2918
16. Heppner, G. H. Tumor Heterogeneity Cancer Res. 1984, 44, 2259-2265
17. Fidler, I. J. Tumor Heterogeneity and Biology of Cancer Invasion and Metastasis Cancer Res. 1978, 38, 2651-2660
18. Heppner, G. H.; Miller, B. E. Tumor Heterogeneity-Biological Implications and Therapeutic Consequences Cancer Met. Rev. 1983, 2, 5-23
19. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L. Stem Cells, Cancer, and Cancer Stem Cells Nature 2001, 414, 105-111
20. Collins, A. T.; Berry, P. A.; Hyde, C.; Stower, M. J.; Maitland, N. J. Prospective Identification of Tumorigenic Prostate Cancer Stem Cells Cancer Res. 2005, 65, 10946-10951
21. Wicha, M. S.; Liu, S. L.; Dontu, G. Cancer Stem Cells: An Old Idea-A Paradigm Shift Cancer Res. 2006, 66, 1883-1890
22. Emmert-Buck, M. R.; Bonner, R. F.; Smith, P. D.; Chuaqui, R. F.; Zhuang, Z. P.; Goldstein, S. R.; Weiss, R. A.; Liotta, L. A. Laser Capture Microdissection Science 1996, 274, 998-1001
23. Simone, N. L.; Bonner, R. F.; Gillespie, J. W.; Emmert-Buck, M. R.; Liotta, L. A. Laser-Capture Microdissection: Opening the Microscopic Frontier to Molecular Analysis Trends Genet. 1998, 14, 272-276
24. Mccabe, A.; Dolled-Filhart, M.; Camp, R. L.; Rimm, D. L. Automated Quantitative Analysis (AQUA) of In Situ Protein Expression, Antibody Concentration, and Prognosis J. Nat. Cancer Inst. 2005, 97, 1808-1815
25. Camp, R. L.; Chung, G. G.; Rimm, D. L. Automated Subcellular Localization and Quantification of Protein Expression in Tissue Microarrays Nat. Med. 2002, 8, 1323-1327
26. Camp, R. L.; Dolled-Filhart, M.; King, B. L.; Rimm, D. L. Quantitative Analysis of Breast Cancer Tissue Microarrays Shows That Both High and Normal Levels of HER2 Expression Are Associated with Poor Outcome Cancer Res. 2003, 63, 1445-1448
27. Rubin, M. A.; Zerkowski, M. P.; Camp, R. L.; Kuefer, R.; Hofer, M. D.; Chinnaiyan, A. M.; Rimm, D. L. Quantitative Determination of Expression of the Prostate Cancer Protein α-Methylacyl-CoA Racemase Using Automated Quantitative Analysis (AQUA)-A Novel Paradigm for Automated and Continuous Biomarker Measurements Am. J. Pathol. 2004, 164, 831-840
28. Levenson, R. M. Spectral Imaging and Pathology: Seeing More Lab Med. 2004, 35, 244-252
29. Cheng, L.; Nagabhushan, M.; Pretlow, T. P.; Amini, S. B.; Pretlow, T. G. Expression of E-Cadherin in Primary and Metastatic Prostate Cancer Am. J. Pathol. 1996, 148, 1375-1380 (Pubitemid 26135881)
30. Pena, J. T. G.; Sohn-Lee, C.; Rouhanifard, S. H.; Ludwig, J.; Hafner, M.; Mihailovic, A.; Lim, C.; Holoch, D.; Berninger, P.; Zavolan, M. et al. MiRNA In Situ Hybridization in Formaldehyde and EDC-Fixed Tissues Nat. Methods 2009, 6, 139-141
31. Weinstein, M. H.; Signoretti, S.; Loda, M. Diagnostic Utility of Immunohistochemical Staining for p63, a Sensitive Marker of Prostatic Basal Cells Mod. Pathol. 2002, 15, 1302-1308
32. Reiner, T.; De Las Pozas, A.; Parrondo, R.; Perez-Stable, C. Progression of Prostate Cancer from a Subset of p63-Positive Basal Epithelial Cells in FG/Tag Transgenic Mice Mol. Cancer Res. 2007, 5, 1171-1179
33. Mirtti, T.; Alanen, K.; Kallajoki, M.; Rinne, A.; Söderström, K. O. Expression of Cystatins, High Molecular Weight Cytokeratin, and Proliferation Markers in Prostatic Adenocarcinoma and Hyperplasia Prostate 2003, 54, 290-298
34. Rhodes, D. R.; Sanda, M. G.; Otte, A. P.; Chinnaiyan, A. M.; Rubin, M. Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer J. Nat. Cancer Inst. 2003, 95, 661-668
35. Mansfield, J. R.; Gossage, K. W.; Hoyt, C. C.; Levenson, R. M. Autofluorescence Removal, Multiplexing, and Automated Analysis Methods for In Vivo Fluorescence Imaging J. Biomed. Optics 2005, 10, 41207
36. Rubin, M. A.; Zhou, M.; Dhanasekaran, S. M.; Varambally, S.; Barrette, T. R.; Sanda, M. G.; Pienta, K. J.; Ghosh, D.; Chinnaiyan, A. M. α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer J. Am. Med. Assoc. 2002, 287, 1662-1670
37. Zhou, M.; Chinnaiyan, A. M.; Kleer, C. G.; Lucas, P. C.; Rubin, M. A. α-Methylacyl-CoA Racemase: A Novel Tumor Marker Over-Expressed in Several Human Cancers and Their Precursor Lesions Am. J. Surg. Pathol. 2002, 26, 926-931
38. Leav, I.; Mcneal, J. E.; Ho, S. M.; Jiang, Z. α-Methylacyl-CoA Racemase (P504S) Expression in Evolving Carcinomas within Benign Prostatic Hyperplasia and in Cancers of the Transition Zone Human Pathol. 2003, 34, 228-233
39. Epstein, J. I.; Herawi, M. Prostate Needle Biopsies Containing Prostatic Intraepithelial Neoplasia or Atypical Foci Suspicious for Carcinoma: Implications for Patient Care J. Urol. 2006, 175, 820-834
40. Montironi, R.; Scattoni, V.; Mazzucchelli, R.; Lopez-Beltran, A.; Bostwick, D. G.; Montorsi, F. Atypical Foci, Suspicious but Not Diagnostic of Malignancy in Prostate Needle Biopsies Eur. Urol. 2006, 50, 666-674
41. Helpap, B.; Bonkhoff, H.; Cockett, A.; Montironi, R.; Troncoso, P.; Waters, D.; Bostwick, D. Relationship between Atypical Adenomatous Hyperplasia (AAH), Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma Pathologica 1997, 89, 288-300
42. McNeal, J. E. In Prostate in Histology for Pathologists, 3rd ed.; Mills, S. E., Ed.; Lippincott Williams & Wilkins: Philadelphia, PA, 2007.
43. Epstein, J. I. What's New In Prostate Cancer Disease Assessment In 2006? Curr. Opin. Urol. 2006, 16, 146-151
44. Holmberg, L.; Bill-Axelson, A.; Helgesen, F.; Salo, J. O.; Folmerz, P.; Häggman, M.; Andersson, S.-O.; Spangberg, A.; Busch, C.; Nordling, S. et al. A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer N. Engl. J. Med. 2002, 347, 781-789
45. Loberg, R. D.; Bradley, D. A.; Tomlins, S. A.; Chinnaiyan, A. M.; Pienta, K. J. The Lethal Phenotype of Cancer: The Molecular Basis of Death Due to Malignancy CA Cancer J. Clin. 2007, 57, 225-241